TOVX
Theriva Biologics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.18
+0.00 -3.20%
🌙 3월 13일 7:51 PM ET (한국 3/14 08:51)
$0.18
+0.00 +2.80%
| Index | - | P/E | - | EPS (ttm) | -4.04 | Insider Own | 2.14% | Shs Outstand | 0.04B | Perf Week | -3.1% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.03B | Perf Month | -14.54% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.05 | Inst Own | 3.63% | Short Float | 17.52% | Perf Quarter | -20.9% |
| Income | -0.03B | P/S | - | EPS this Y | 90.38% | Inst Trans | 3.54% | Short Ratio | 0.61 | Perf Half Y | -58.35% |
| Sales | 0.00B | P/B | 0.41 | EPS next 5Y | - | ROA | -56.91% | Short Interest | 6.12M | Perf YTD | -16.73% |
| Book/sh | 0.43 | P/C | 0.62 | EPS past 3/5Y | 60.07% 58.31% | ROE | -137.82% | 52W High | -88.32% ($1.50) | Perf Year | -84.22% |
| Cash/sh | 0.28 | P/FCF | - | Sales past 3/5Y | - | ROIC | -145.06% | 52W Low | 7.62% ($0.16) | Perf 3Y | -99.09% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 84.86% | Gross Margin | - | Volatility(W/M) | 3.9% 8.55% | Perf 5Y | -99.92% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.02 | Perf 10Y | -100% |
| Dividend Ex-Date | 2007/12/27 | Quick Ratio | 1.74 | EPS Q/Q | 93.86% | Profit Margin | - | RSI (14) | 42.16 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.74 | Sales Q/Q | - | SMA20 | -6.21% ($0.19) | Beta | 0.52 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.17 | Earnings | 3000000 | SMA50 | -11.01% ($0.2) | Rel Volume | 0.19 | Prev Close | $0.18 |
| Employees | 16 | LT Debt/Eq | 0.13 | EPS/Sales Surpr. | 525.29% - | SMA200 | -47.59% ($0.34) | Avg Volume(3M) | 10.03M | Price | $0.18 |
| IPO | 1993/4/5 | Option/Short | No/Yes | Trades | 1280 | Volume | 1,928,017 | Change | -3.2% |
뉴스 로딩 중...